Rchr
J-GLOBAL ID:201201062622362847
Update date: Jan. 30, 2024
Okamoto Shozo
オカモト ショウゾウ | Okamoto Shozo
Affiliation and department:
Homepage URL (1):
http://kaken.nii.ac.jp/d/r/20431364.ja.html
Research field (1):
Radiology
Research keywords (13):
トランスレーショナルリサーチ
, 核医学(PET,SPECT)
, 画像診断学(含放射線診断学、核医学)
, 小動物(ラット)
, 心臓(心筋)
, 循環器
, 遺伝子治療
, 血管新生
, 遺伝子発現イメージング
, 再生医療
, 分子イメージング
, 虚血性心疾患
, レポーター遺伝子
Research theme for competitive and other funds (3):
- 2017 - 2020 Establishment of a new evaluation of tumor hypoxia using FDiFA-PET
- 2013 - 2016 Reoxygenation by radiation for dose escalated radiation therapy
- 2006 - 2008 Radionuclide reporter gene imaging for cardiac gene therapy
Papers (36):
-
Shiro Watanabe, Shozo Okamoto, Kazumasa Akikawa, Noriyuki Miyamoto, Miyuki Okamura-Kawasaki, Yuko Uchiyama, Junki Takenaka, Takuya Toyonaga, Kenji Hirata, Kohsuke Kudo. Identification of patients with Graves' disease who benefit from high-dose radioactive iodine therapy. Annals of nuclear medicine. 2022
-
Yuko Uchiyama, Kenji Hirata, Shiro Watanabe, Shozo Okamoto, Tohru Shiga, Kazufumi Okada, Yoichi M. Ito, Kohsuke Kudo. Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma. Annals of Nuclear Medicine. 2021
-
Keiichiro Yoshinaga, Takashige Abe, Shozo Okamoto, Yuko Uchiyama, Osamu Manabe, Yoichi M Ito, Naomi Tamura, Natsue Ito, Naho Yoshioka, Komei Washino, et al. Effects of Repeated 131I-Meta-Iodobenzylguanidine Radiotherapy on Tumor Size and Tumor Metabolic Activity in Patients with Metastatic Neuroendocrine Tumors. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2021. 62. 5. 685-694
-
Shozo Okamoto, Tohru Shiga, Nagara Tamaki. Clinical Perspectives of Theranostics. Molecules (Basel, Switzerland). 2021. 26. 8
-
Shiro Watanabe, Ken-Ichi Nishijima, Shozo Okamoto, Keiichi Magota, Kenji Hirata, Takuya Toyonaga, Tohru Shiga, Yuji Kuge, Nagara Tamaki. Biodistribution and internal radiation dosimetry of a novel probe for thymidine phosphorylase imaging, [123I]IIMU, in healthy volunteers. Annals of nuclear medicine. 2020
more...
MISC (79):
-
久下裕司, 東川 桂, 岡本祥三, 志賀 哲. Nuclear Medicine Today 2018 最新トピックスから探る核医学の現在と未来 ?Theranosticsに向けた研究開発の最新トピックス 5.68Ge/68Gaジェネレータを用いるPET薬剤の研究開発と将来展望。. INNERVISION. 2018. 33. 11. 58-61
-
岡本祥三, 志賀 哲, 久下裕司. Nuclear Medicine Today 2018 最新トピックスから探る核医学の現在と未来 ?Theranosticsに向けた研究開発の最新トピックス 4.前立腺がんに対するPSMA-PETとPSMAによるアイソトープ治療の最新動向。. INNERVISION. 2018. 33. 11. 55-57
-
T. Inoue, S. Watanabe, K. Harada, K. Yasuda, N. Katoh, S. Okamoto, T. Shiga, Y. Kuge, N. Tamaki, H. Shirato. Can F-18-fluoromisonidazole PET/CT Predict the Clinical Outcome for Stage I Non-small Cell Lung Cancer Treated By Stereotactic Body Radiation Therapy?. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2017. 99. 2. E466-E466
-
渡邊 史郎, 内山 裕子, 岡本 祥三, 志賀 哲. TKI時代における転移再発甲状腺分化癌の放射線治療 放射性ヨード内用療法抵抗性の判断・適切なTKIへの橋渡し 核医学の立場から. 日本内分泌・甲状腺外科学会雑誌. 2017. 34. Suppl.2. S224-S224
-
志賀 哲, 内山 裕子, 岡本 祥三, 平田 健司, 渡邊 史郎, 真鍋 治, 玉木 長良. 巨大甲状腺腫を伴うバセドウ病に対するI-131 30mCi 1回投与に関する検討. 核医学. 2017. 54. Suppl. S176-S176
more...
Professional career (1):
Work history (1):
- 2008 - Hokkaido University
Return to Previous Page